How much funding has Epix Therapeutics raised?

Epix Therapeutics has raised $45.0M in total funding, most recently a Venture Round.

Who are Epix Therapeutics's investors?

Epix Therapeutics's investors include Medtronic, Ajax Health, New Enterprise Associates, Questa Capital Management.

When was Epix Therapeutics founded?

Epix Therapeutics was founded in 2007.

Where is Epix Therapeutics headquartered?

Epix Therapeutics is headquartered in Boulder, Colorado, United States.

What industry is Epix Therapeutics in?

Epix Therapeutics operates in Cardiac Ablation, Medical Devices.

How many employees does Epix Therapeutics have?

Epix Therapeutics has 11-50 employees.

Epix Therapeutics

Closed

Boulder, United States · Founded 2007 · $45.0M raised

Cardiac Ablation

Medical Devices

Headquarters: Boulder, Colorado
Employees: 11–50
Founded: 2007
Business Model: B2B

Website: epixtherapeutics.com
Total Funding: $45.0M
Last Round: $45.0M Venture RoundMay 2017
Rounds: 1

About

EPIX Therapeutics (formerly Advanced Cardiac Therapeutics) developed catheter-based radiofrequency ablation systems for treating atrial fibrillation, using microwave radiometry technology for real-time tissue temperature monitoring. The company was acquired by Medtronic in March 2019 for $316 million.

Summary

Epix Therapeutics is a Cardiac Ablation company based in Boulder, United States, founded in 2007. It has raised $45.0M in total across 1 round, most recently a $45.0M Venture Round round in May 2017. Investors include Medtronic, Ajax Health and New Enterprise Associates.